Silymarin inhibits TNF-α-induced expression of adhesion molecules in human umbilical vein endothelial cells

FEBS Letters

Volumn 550, Issue 1-3, 2003, Pages 89-93

  Kang, Jong Soon ^a   Park, Song Kyu ^a   Yang, Kyu Hwan ^a,b   Kim, Hwan Mook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

E selectin; ICAM 1; NF B Rel; Silymarin; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR CELL ADHESION MOLECULE; SILYMARIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; UMBILICAL VEIN;

EID: 0142039011     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00827-5     Document Type: Article

References (34)

1. Ludewig B., Zinkernagel R.M., Hengartner H. Trends Cardiovasc. Med. 12:2002;154-159.
2. Glass C.K., Witztum J.L. Cell. 104:2001;503-516.
3. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. Cell. 60:1990;577-584.
4. Davies M.J., Gordon J.L., Gearing A.J., Pigott R., Woolf N., Katz D., Kyriakopoulos A. J. Pathol. 171:1993;223-229.
5. O'Brien K.D., et al. J. Clin. Invest. 92:1993;945-951.
6. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. J. Exp. Med. 191:2000;189-194.
7. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. J. Clin. Invest. 102:1998;145-152.
8. Ghosh S., May M.J., Kopp E.B. Annu. Rev. Immunol. 16:1998;225-260.
9. Iademarco M.F., McQuillan J.J., Rosen G.D., Dean D.C. J. Biol. Chem. 267:1992;16323-16329.
10. Ledebur H.C., Parks T.P. J. Biol. Chem. 270:1995;933-943.
11. Whelan J., Ghersa P., Hooft van Huijsduijnen R., Gray J., Chandra G., Talabot F., DeLamarter J.F. Nucleic Acids Res. 19:1991;2645-2653.
12. Valenzuela A., Garrido A. Biol. Res. 27:1994;105-112.
13. Mereish K.A., Bunner D.L., Ragland D.R., Creasia D.A. Pharm. Res. 8:1991;273-277.
14. Carini R., Comoglio A., Albano E., Poli G. Biochem. Pharmacol. 43:1992;2111-2115.
15. Manna S.K., Mukhopadhyay A., Van N.T., Aggarwal B.B. J. Immunol. 163:1999;6800-6809.
16. Kang J.S., Jeon Y.J., Kim H.M., Han S.H., Yang K.H. J. Pharmacol. Exp. Ther. 302:2002;138-144.
17. Bialecka M. Ann. Acad. Med. Stetin. 43:1997;41-56.
18. Locher R., Suter P.M., Weyhenmeyer R., Vetter W. Arzneimittelforschung. 48:1998;236-239.
19. Skottova N., Krecman V. Physiol. Res. 47:1998;1-7.
20. Oh G.T., et al. Atherosclerosis. 159:2001;17-26.
21. Gupta B., Ghosh B. Int. J. Immunopharmacol. 21:1999;745-757.
22. Jeon Y.J., Kim Y.K., Lee M., Park S.M., Han S.B., Kim H.M. J. Pharmacol. Exp. Ther. 294:2000;548-554.
23. Chomczynski P., Mackey K. Anal. Biochem. 225:1995;163-164.
24. Pierce J.W., Lenardo M., Baltimore D. Proc. Natl. Acad. Sci. USA. 85:1988;1482-1486.
25. Saliou C., Rihn B., Cillard J., Okamoto T., Packer L. FEBS Lett. 440:1998;8-12.
26. Chen A.F., Ren J., Miao C.Y. Jpn. J. Pharmacol. 89:2002;327-336.
27. Fremont L., Belguendouz L., Delpal S. Life Sci. 64:1999;2511-2521.
28. Brito P., Almeida L.M., Dinis T.C. Free Radic. Res. 36:2002;621-631.
29. Ferrero M.E., et al. Am. J. Clin. Nutr. 68:1998;1208-1214.
30. Wolle J., Hill R.R., Ferguson E., Devall L.J., Trivedi B.K., Newton R.S., Saxena U. Arterioscler. Thromb. Vasc. Biol. 16:1996;1501-1508.
31. Luiz da Silva E., Tsushida T., Terao J. Arch. Biochem. Biophys. 349:1998;313-320.
32. da Silva E.L., Abdalla D.S., Terao J. IUBMB Life. 49:2000;289-295.
33. Di Carlo G., Mascolo N., Izzo A.A., Capasso F. Life Sci. 65:1999;337-353.
34. Zhao J., Agarwal R. Carcinogenesis. 20:1999;2101-2108.